Manteio Capital’s UnitedHealth UNH Stock Holding History

Manteio Capital’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-594	Closed	-$298K	–	200
2021 Q4	$298K	Buy	+594	New	+$269K	0.38%	101

Other funds holding UNH

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Manteio Capital's UNH Position: Q1 2022 in Review

Manteio Capital sold out of UnitedHealth (UNH) in Q1 2022, closing a stake of 594 shares — an estimated $298K sold.

Manteio Capital first reported a position in UNH in Q4 2021 and held it in 1 quarter. The position peaked at $298K in Q4 2021. 2,961 funds tracked by Wall St. Rank hold UNH as of Q1 2022.

Manteio Capital reported no remaining UnitedHealth position as of Q1 2022 after selling out during the quarter.
Manteio Capital sold 594 UnitedHealth shares in Q1 2022, an estimated $298K.
Manteio Capital first reported a position in UnitedHealth in Q4 2021 and held it in 1 quarter.
Manteio Capital's UnitedHealth position peaked at $298K in Q4 2021.
2,961 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2022.

Based on Manteio Capital's 13F filing for Q1 2022.